reproductive technology cycles in

are two options for patients accessing treatment: either meeting specified criteria for age, no smoking and BMI for publicly funding or funding their own treatment. This differs from Australia, which has no explicit eligibility criteria restricting access to fertility treatment. An analysis of assisted reproductive technology (ART) in Australia and NZ was undertaken to consider the impact of these different funding approaches. methods: Data were extracted from the Australian and New Zealand Assisted Reproduction Database between 2004 and 2007. A total of 116 111 autologous fresh cycles were included. results: In Australia, more cycles were in women aged 40 years or older compared with those in NZ (23.5 versus 16.0%, P, 0.01). Single embryo transfer was more common in NZ than that in Australia, in women, 35 years of age (75.1 versus 59.6%, P, 0.01). In women,35 years, the crude rates of clinical pregnancy (37.5 versus 31.2%, P, 0.01) and live delivery (31.6 versus 26%, P, 0.01) following fresh ART cycles were significantly higher in NZ than that in Australia. These differences in outcomes persisted in older age groups. conclusions: The purpose of the criteria used in NZ to access public funding for fertility treatments is to optimize pregnancy out-comes. This approach has resulted in a healthier population of women undergoing treatment and may explain the improved pregnancy out-comes seen in NZ couples who undergo fertility treatments